These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35158947)

  • 21. Medulloblastoma in Adults: Cytogenetic Phenotypes Identify Prognostic Subgroups.
    Goschzik T; Zur Muehlen A; Doerner E; Waha A; Friedrich C; Hau P; Pietsch T
    J Neuropathol Exp Neurol; 2021 Apr; 80(5):419-430. PubMed ID: 33870422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The evolution of medulloblastoma therapy to personalized medicine.
    Sengupta S; Pomeranz Krummel D; Pomeroy S
    F1000Res; 2017; 6():490. PubMed ID: 28713553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical implications of medulloblastoma subgroups: incidence of CSF diversion surgery.
    Schneider C; Ramaswamy V; Kulkarni AV; Rutka JT; Remke M; Tabori U; Hawkins C; Bouffet E; Taylor MD
    J Neurosurg Pediatr; 2015 Mar; 15(3):236-42. PubMed ID: 25525930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the PI3K/AKT/mTOR signaling pathway in medulloblastoma.
    Dimitrova V; Arcaro A
    Curr Mol Med; 2015; 15(1):82-93. PubMed ID: 25601471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complete and sustained response of adult medulloblastoma to first-line sonic hedgehog inhibition with vismodegib.
    Lou E; Schomaker M; Wilson JD; Ahrens M; Dolan M; Nelson AC
    Cancer Biol Ther; 2016 Oct; 17(10):1010-1016. PubMed ID: 27682250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of CD24 as a marker of Patched1 deleted medulloblastoma-initiating neural progenitor cells.
    Robson JP; Remke M; Kool M; Julian E; Korshunov A; Pfister SM; Osborne GW; Taylor MD; Wainwright B; Reynolds BA
    PLoS One; 2019; 14(1):e0210665. PubMed ID: 30657775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.
    Robinson GW; Rudneva VA; Buchhalter I; Billups CA; Waszak SM; Smith KS; Bowers DC; Bendel A; Fisher PG; Partap S; Crawford JR; Hassall T; Indelicato DJ; Boop F; Klimo P; Sabin ND; Patay Z; Merchant TE; Stewart CF; Orr BA; Korbel JO; Jones DTW; Sharma T; Lichter P; Kool M; Korshunov A; Pfister SM; Gilbertson RJ; Sanders RP; Onar-Thomas A; Ellison DW; Gajjar A; Northcott PA
    Lancet Oncol; 2018 Jun; 19(6):768-784. PubMed ID: 29778738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GSK-3 modulates SHH-driven proliferation in postnatal cerebellar neurogenesis and medulloblastoma.
    Ocasio JK; Bates RDP; Rapp CD; Gershon TR
    Development; 2019 Oct; 146(20):. PubMed ID: 31540917
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G-protein coupled receptor expression patterns delineate medulloblastoma subgroups.
    Whittier KL; Boese EA; Gibson-Corley KN; Kirby PA; Darbro BW; Qian Q; Ingram WJ; Robertson T; Remke M; Taylor MD; O'Dorisio MS
    Acta Neuropathol Commun; 2013 Oct; 1():66. PubMed ID: 24252460
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SHH inhibitors for the treatment of medulloblastoma.
    Samkari A; White J; Packer R
    Expert Rev Neurother; 2015; 15(7):763-70. PubMed ID: 26027634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating Molecular Subclassification of Medulloblastomas into Routine Clinical Practice: A Simplified Approach.
    Kaur K; Kakkar A; Kumar A; Mallick S; Julka PK; Gupta D; Suri A; Suri V; Sharma MC; Sarkar C
    Brain Pathol; 2016 May; 26(3):334-43. PubMed ID: 26222673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A simplified approach using Taqman low-density array for medulloblastoma subgrouping.
    Cruzeiro GAV; Salomão KB; de Biagi CAO; Baumgartner M; Sturm D; Lira RCP; de Almeida Magalhães T; Baroni Milan M; da Silva Silveira V; Saggioro FP; de Oliveira RS; Dos Santos Klinger PH; Seidinger AL; Yunes JA; de Paula Queiroz RG; Oba-Shinjo SM; Scrideli CA; Nagahashi SMK; Tone LG; Valera ET
    Acta Neuropathol Commun; 2019 Mar; 7(1):33. PubMed ID: 30832734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumours.
    Łastowska M; Jurkiewicz E; Trubicka J; Daszkiewicz P; Drogosiewicz M; Malczyk K; Grajkowska W; Matyja E; Cukrowska B; Pronicki M; Perek-Polnik M; Perek D; Dembowska-Bagińska B
    J Neurooncol; 2015 May; 123(1):65-73. PubMed ID: 25862008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma.
    Zou H; Poore B; Broniscer A; Pollack IF; Hu B
    Cancers (Basel); 2020 Mar; 12(3):. PubMed ID: 32164294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Medulloblastoma: Molecular understanding, treatment evolution, and new developments.
    Liu X; Ding C; Tan W; Zhang A
    Pharmacol Ther; 2020 Jun; 210():107516. PubMed ID: 32105673
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are molecular subgroups of medulloblastomas really prognostic?
    Frappaz D; Faure-Conter C; Meyronet D; Levard-Bonneville A; Beuriat PA; Sunyach MP; Barritault M
    Curr Opin Neurol; 2018 Dec; 31(6):747-751. PubMed ID: 30300240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nomograms based on preoperative multiparametric magnetic resonance imaging for prediction of molecular subgrouping in medulloblastoma: results from a radiogenomics study of 111 patients.
    Dasgupta A; Gupta T; Pungavkar S; Shirsat N; Epari S; Chinnaswamy G; Mahajan A; Janu A; Moiyadi A; Kannan S; Krishnatry R; Sastri GJ; Jalali R
    Neuro Oncol; 2019 Jan; 21(1):115-124. PubMed ID: 29846693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.